Overview

This book is designed to familiarize clinical practitioners in systemic therapy options and medical management of urologic malignancies including prostate cancer, bladder and upper tract urothelial carcinoma, and renal cell carcinoma. Organized by organ system, the text highlights new therapies such as novel forms of androgen deprivation, cytotoxic chemotherapy, immune check point and immunomodulatory agents, and targeted therapies. Written by experts in the field, the book also reviews current chemotherapy and immunotherapy regimens for genitourinary malignancies and discusses indications, outcomes, and toxicities, as well as clinical trial concepts. Each of the book’s chapters offers a bulleted box of clinical pearls on the particular role of the APP. Chemotherapy and Immunotherapy in Urologic Oncology: A Guide for the Advanced Practice Provider is a resource for urologists, uro-radiologists, medical clinicians and family practitioners alike, familiarizing its audiences with systemic therapy regimens for urologic malignancies, as well as their expected outcomes and side effects. 

Full Product Details

Author:   Edouard J. Trabulsi ,  Costas D. Lallas ,  Anne E. Lizardi-Calvaresi
Publisher:   Springer Nature Switzerland AG
Imprint:   Springer Nature Switzerland AG
Edition:   1st ed. 2021
Weight:   0.498kg
ISBN:  

9783030520205

ISBN 10:   303052020
Pages:   307
Publication Date:   29 September 2020
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Paperback
Publisher's Status:   Active
Availability:   Manufactured on demand  
We will order this item for you from a manufactured on demand supplier.

Table of Contents

Introduction: Integration of APP into Urologic Oncology Practice.- Overview and Active Surveillance of Prostate Cancer.- Monitoring and Managing Men Following Initial Treatment of Prostate Cancer.- Radical Prostatectomy and Survivorship after Radical Prostatectomy.- Multimodal Treatment Plans in Prostate Cancer.- Radiotherapy for Prostate Cancer.- Androgen Deprivation Treatment.- Second Generation Androgen Targeted Agents.- Chemotherapy and prostate cancer.- Radiopharmaceuticals for Prostate Cancer.- Immunotherapy and Novel Agents on the Horizon for the Treatment of Prostate Cancer.- Bladder Cancer.- Intravesical Therapy for Non Muscle Invasive Urothelial Carcinoma.- Bladder Cancer: Muscle Invasive Disease.- Chemoradiation Bladder Preservation.- Metastatic Bladder Cancer and the Use of Cisplatin Chemotherapy.- Immunotherapy for Metastatic Urothelial Cancer.- Novel and experimental Strategies in the treatment of Metastatic Urothelial Carcinoma.- Upper Tract Urothelial Carcinoma.- KidneyCancer and Its Treatment.- Targeted Therapies for Treatment of Metastatic Renal Cell Carcinoma.- Immune Therapies for Metastatic Kidney Cancer.- Novel Therapies for Renal Cell Carcinoma.- Testicular Cancer.- Penile Cancer.

Reviews

Author Information

Edouard J. TrabulsiDirector, Multidisciplinary Genitourinary Oncology CenterDirector, Division of Urologic Oncology, Department of UrologyCo-Director, Prostate Diagnostic CenterProfessor and Vice Chair of ResearchDepartment of UrologySidney Kimmel Medical College atThomas Jefferson UniversityPhiladelphia, PAUSA Costas D. LallasProfessor and Vice Chair of Academic AffairsDepartment of UrologySidney Kimmel Medical College atThomas Jefferson UniversityPhiladelphia, PAUSA Anne E. Lizardi-CalvaresiDirector of Clinical OperationsUrology Nurse PractitionerSidney Kimmel Medical College atThomas Jefferson UniversityPhiladelphia, PAUSA

Tab Content 6

Author Website:  

Countries Available

All regions